HCM Earnings

HCM reported its earnings on 2026-03-05, showcasing a revenue of 548.51M against an estimate of 602.41M, resulting in a -8.95% surprise. The EPS was 2.62, surpassing the expected 1.43 by 83.22%. The stock experienced a 1.5% price change on the earnings day and a 1.8% change over the next five days, reflecting market reactions to the results.

Following HCM's earnings announcement on 2026-03-05, the stock price moved by 1.5% on the day of the release. Over the subsequent five days, it saw a 1.8% change. Historically, HCM's stock price tends to shift by an average of 4.31% in the 10 days leading up to earnings and 0.93% in the 10 days following, providing insight into potential market.

For , analysts estimate HCM's annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised upward by 2.54% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HCM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were revised upward by 2.54%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HCM's stock price typically moves by 4.31% in the 10 days before its earnings and 0.93% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call shows mixed signals: Basic Financial Performance is neutral due to stable cash position, but competition impacts sales. Product Development is slightly positive with new indications and partnerships, yet lacks clarity on some projects. Market Strategy is neutral due to restructuring impacts and unclear guidance. Expenses are neutral with planned R&D investment. Shareholder Return Plan is not explicitly mentioned. Q&A reveals uncertainties in guidance and project timelines, offsetting positive growth expectations. Overall, the market reaction is expected to be neutral, with limited impact on the stock price.